Secondly, many potential early marker of PD are significantly abnormal in iRBD, such as decreased striatal dopamine transporter binding, marked EEG slowing, substantial nigra hyperechogenicity and impaired olfaction [28–30]. Here, SLC6A3 is linked to Parkinson disease.